Replies to post #30910 on Anavex Life Sciences Corp (AVXL)

[shoeman6]

This would also be consistent with a presentation of Full Phase 2A data. The previous abstract spoke to the ongoing Phase 2B trial of which there is only preliminary data. Perhaps someone thought it would be improper to speak to Phase 2B data in the abstract of the completed clinical trial (I tend to agree). We will see this weekend.